{
    "title": "Alzheimer's drug shows promise in early results of study",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11258709/Alzheimers-drug-shows-promise-early-results-study.html",
    "date": "2022-09-28",
    "keywords": [
        "biogen",
        "treatment",
        "drug",
        "disease",
        "study",
        "co",
        "year",
        "eisai",
        "protein",
        "latestage",
        "lecanemab",
        "decline",
        "tuesday",
        "research",
        "approval",
        "file",
        "inc",
        "cambridge",
        "wednesday",
        "brain",
        "market",
        "price",
        "tag",
        "plaque",
        "drugmaker",
        "placebo",
        "scale",
        "ability",
        "ltd",
        "conference",
        "november",
        "journal",
        "company",
        "food",
        "administration",
        "agency",
        "headquarters",
        "mass",
        "progress",
        "earlystage",
        "senne",
        "caution",
        "mizuho",
        "analyst",
        "graig",
        "suvannavejh",
        "note",
        "statement",
        "association",
        "date",
        "memory",
        "communication",
        "cure",
        "manage",
        "evidence",
        "progression",
        "coverage",
        "benefit",
        "medicare",
        "program",
        "spending",
        "aduhelm",
        "betaamyloid",
        "contributor",
        "family",
        "history",
        "donanemab",
        "stock",
        "aduhelms",
        "debut",
        "eli"
    ],
    "category": [
        "wires",
        "ap"
    ]
}